Primate Pulpal Healing after Exposure and TheraCal Application

The purpose of this in vivo study was to compare the effectiveness of a new light cured resin based dicalcium/tricalcium silicate pulp capping material (TheraCal LC, Bisco), pure Portland cement, resin based calcium hydroxide or glass ionomer in the healing of bacterially contaminated primate pulps. Study design: The experiment required four primates each having 12 teeth prepared with buccal penetrations into the pulpal tissues with an exposure of approximately 1.0 mm. The exposed pulps of the primate teeth were covered with cotton pellets soaked in a bacterial mixture consisting of microorganisms normally found in human pulpal abscesses. After removal of the pellet, hemostasis was obtained and the pulp capping agents applied. The light cured resin based pulp capping material (TheraCal LC) was applied to the pulpal tissue of twelve teeth with a needle tip syringe and light cured for 15 seconds. Pure Portland cement mixed with a 2% Chlorhexidine solution was placed on the exposed pulpal tissues of another twelve teeth. Twelve additional teeth had a base of GIC applied (Triage, Fuji VII GC America) and another twelve had a pulp cap with VLC DYCAL (Dentsply), a light cured calcium hydroxide resin based material. The pulp capping bases were then covered with a RMGI (Fuji II LC GC America). The tissue samples were collected at 4 weeks. The samples were deminerilized, sectioned, stained and histologically graded. Results: There were no statistically significant differences between the groups in regard to pulpal inflammation (H= 0.679, P=1.00). However, both the Portland cement and light cured TheraCal LC groups had significantly more frequent hard tissue bridge formation at 28 days than the GIC and VLC Dycal groups (H= 11.989, P=0.009). The measured thickness of the hard tissue bridges with the pure Portland and light cured TheraCal LC groups were statistically greater than that of the other two groups (H= 15.849, P=0.002). In addition, the occurrence of pulpal necrosis was greater with the GIC group than the others. Four premolars, one each treated according to the protocols were analyzed with a microCT machine. The premolar treated with the light cured TheraCal LC demonstrated a complete hard tissue bridge. The premolar treated with the GIC did not show a complete hard tissue bridge while the premolar treated with VLC Dycal had an incomplete bridge. The pure Portland with Chlorhexidine mixture created extensive hard tissue bridging. Conclusion: TheraCal LC applied to primate pulps created dentin bridges and mild inflammation acceptable for pulp capping.

pulp exposures, pulp response, bacteria, primate

1 Ranly, DM. Pulpotomy therapy in primary teeth: new modalities for old relationales. Pediatr. Dent. v.16, p.403-9, 1994.

2 Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J. Endod. v.12, p.591-95, 1993.

3 Torabinejad, M. et al. Physical and chemical properties of a new root-end filling material. J. Endod. v.21, n.7, p. 349-353, 1995.

4 Lee S, Monsef M., Torabinejad M. Sealing ability of a mineral trioxide aggregate for repair of lateral root perforations. J. Endod. v.19, n.11, nov. 1993.

5 Aqrabawi J. Sealing ability of amalgam, Super EBA cement, and MTA when used as retrograde filling materials. Br. Dent. J, v.188, n.5, p.266-268, 2000.

6 Torabinejad M, Ford TR, Abedi HR, Kariyawasam SP, Tang HM.. Tissue reaction to implanted Super EBA and mineral trioxide aggregate in the mandible of guinea pigs: a preliminary report. J. Endod. v.21, n.11, p.569-71, 1995.

7 Koh ET, Torabinejad M, Pitt Ford TR, Brady K, McDonald F. Mineral trioxide aggregate stimulates a biological response in human osteoblasts. J. Biomed. Mater Res.v.37, n.3, p.432-9, 1997.

8 Moretton TR, Brown CE JR, Legan JJ, Kafrawy AH. Tissue reactions after subcutaneous and intraosseous implantation of mineral trioxide aggregate and ethoxybenzoic acid cement. J. Biomed. Mater. Res. v.52, n.3, p.528- 533, 2000.

9 Kettering JD, Torabinejad M. Investigation of mutagenicity of mineral trioxide aggregate and other commonly used root-end filling materials. J. Endod, v.21, n.11, 1995.

10 Keiser K, Johnson C, Tipton DA. Citotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J. Endod, v.26, n.5, p. 288-291, 2000.

11 Koh ET, McDonald F, Pitt Ford TR, Torabinejad M. Cellular response to mineral trioxide aggregate. J. Endod. v.24, n.8, p.543-7, 1998.

12 Schwartz RS, Mauger M, Clement DJ, Walker WA 3rd.. Mineral trioxide aggregate: anew material for endodontics. J. Am. Dent. Assoc, v.30, p.969- 75, 1999.

13 Abedi HR et al. The use of mineral trioxide aggregate cement as a direct pulp capping agent. J. Endod. v.22, n.4, p.199, 1996.

14 Holland R, Souza V, Nery MJ, Faraco Junior IM, Bernabe PF, Otoboni Filho JA, Dezan Junior E. Reaction of rat connective tissue to implanted dentin tube filled with mineral trioxide aggregate, portland cement or calcium hydroxide. Braz. Dent. J. v.112, p.3-8, 2001.

15 Holland R, Souza V, Nery MJ, Faraco Junior IM, Bernabe PF, Otoboni Filho JA, Dezan Junior E.. Reaction of rat connective tissue to implanted dentin tubes filled with mineral trioxide aggregate or calcium hydroxide. J. Endod. v.25, n.3, p.161-6, 1999.

16 Pitt Ford TR, Torabinjad M, Abedi HR, Bakland LK, Kaylyawawam SP. Using mineral trioxide aggregate as a pulp capping material. J. Am. Dent. Assoc. v.127, n.10, p.1491-4, 1996.

17 Pitt Ford TR, Roberts GJ. Immediate and delayed direct pulp capping with the use of a new visible light-cured calcium hydroxide preparation. Oral Surg Oral Med Oral Pathol. 1991: Mar; 71(3):338-42.

18 Holland R, de Souza V, Murata SS, Nery MJ, Bernabe PF, Otoboni Filho JA, Dezan Junior E. Healing process of dog dental pulps after pulpotomy and pulp covering with mineral trioxide aggregate or Portland cement. Braz Dent J. 2001, 12(2):109-13.

19 Estrela C, Bammann LL, Estrela CR, Silva RS, Pecora JD. Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal. Braz Dent J. 2000;11(1):3-9.

20 Saidon J, He J, Zhu Q, Safavi K, Sapangberg LS. Cell and tissue reactions to mineral trioxide aggregate and Portland cement. Oral Surg Oral Med Oral Path Oral Radio Endod. 2003 Apr,95(4):483-9.

21 Menezes R, Bramante CM, Letra A, Carvalho VG, Garcai RB. Histologic evaluation of pulpotomies in dog using two types of mineral trioxide aggregate and regular and white Portland cements as wound dressings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):376-9.

22 Funteas UR,Wallace JA, Fochtman EW. A comparative analysis of Mineral Trioxide Aggregate and Portland cement. Aust Endod J. 2003 Apr; 29(1):43-4.

23 De Deus, G. et al. Cytotoxicity of MTA and Portland cement on human ECV 304 endothelial cells. Int Endod J. v. 38 Issue 9 p. 604, 2005.